EPO and hypertensive disorder: In animal models, mice expressing high level of transgenic EPO (tg6) with high hematocrit did not develop hypertension due to markedly increased levels of eNOS and NO in vascular tissue and in the circulation, and EPO treatment in rodents was also observed to stimulate NO production [80,81,82].